Botanical species · safety record

Cedrus deodara

The EFSA Compendium of Botanicals holds 3 constituent measurements and 3 adverse-effect records for Cedrus deodara. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cedrus deodara (Roxb. ex D.Don) G.Don

3Constituent measurements

3Safety records

4Cited sources

4Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Cedrus deodara as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Stem
Stem heartwood
Stem(s)
Wood

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Camphor	Leaves	Essential oil	5.2 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	2.1 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	12.5 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Roots and other underground parts	Essential oil (as part-nature)	Rat (as animal)	Acute toxicity	No resolvable identifier
Hepatotoxicity	Liver	Roots and other underground parts	Essential oil (as part-nature)	Rat (as animal)	Acute toxicity	No resolvable identifier
Nephrotoxicity	Urogenital: kidneys	Roots and other underground parts	Essential oil (as part-nature)	Rat (as animal)	Acute toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Yatagai, Mitsuyoshi., Sato, Toshiya. Terpenes of leaf oils from conifers. Biochemical systematics and ecology, 1986, p. 469-478.
Parveen, Rehana., Azmi, Muhammad A., Naqvi, Syed Naeemul H., Mahmood, Syed M., Zaidi, Ijaz H. Effect of Cedrus deodara (Pinaceae) Root Oil on the Histopathology of Rat Liver and Kidney . Tropical journal of pharmaceutical research, 2010, vol. 9, no. 2, p. 127-133.
Perveen, Rehana., Azmi, Mohammad Ahmed., Zaidi, Ijaz Hussain., Naqvi, Syed Naeemul Hassan., Mahmood, Syed Mohammad., Ajmal, Kiran., Usman, Mohammad. Assessment of Cedrus deodara root oil on the histopathological changes in the gastrointestinal tissues in rats . Pakistan journal of pharmaceutical sciences, 2013, vol. 26, no. 3, p. 571-576.
Lee, Na-Hyun., Lee, Sang-Min., Lee, Tae-Min., Chung, Namhyun., Lee, Hoi-Seon. GC-MS Analyses of the Essential Oils Obtained from Pinaceae Leaves in Korea. JOURNAL OF ESSENTIAL OIL BEARING PLANTS, 2015, vol. 18, no. 3, p. 538-542. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature